Literature DB >> 14628962

Emergency resection of an extra-adrenal phaeochromocytoma: wrong or right? A case report and a review of literature.

J C Bos1, A W F T Toorians, J C van Mourik, R J M Strack van Schijndel.   

Abstract

Phaeochromocytomas are rare neuroendocrine tumours that produce symptoms through excess release of catecholamines. Treatment of choice is elective, complete surgical removal after pretreatment with alpha-adrenergic blocking drugs, to prevent dangerous haemodynamic fluctuations. In rare cases a 'catecholamine crisis' develops presenting with pulmonary oedema and circulatory shock. We report such a case of a patient with familial extra-adrenal phaeochromocytoma who successfully underwent emergency surgery. Pathophysiological mechanisms are discussed. Although pretreatment with alpha-adrenergic blocking drugs seems advisable in terms of morbidity and mortality, the concept is based on theory rather than clinical evidence. Surgical management of a catecholamine crisis is associated with high mortality rates. However, proof of better outcome by avoidance or discontinuation of emergency surgery is not available. Based on literature and on this case, we conclude that emergency surgery in phaeochromocytoma does not have to be structurally avoided and may be considered under life-threatening circumstances.

Entities:  

Mesh:

Year:  2003        PMID: 14628962

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  2 in total

1.  Clinical characteristics and outcomes of pheochromocytoma crisis: a literature review of 200 cases.

Authors:  Y Ando; Y Ono; A Sano; N Fujita; S Ono; Y Tanaka
Journal:  J Endocrinol Invest       Date:  2022-07-20       Impact factor: 5.467

2.  Pheochromocytoma revealed by acute heart failure. When should we operate? Presented at the ESES Congress, Gothenburg May 25-26, 2012.

Authors:  G Müller; F Saint; A Hamy; J C Lifante; B Carnaille; F Sebag; F Ménégaux; J Vandwalle; D Drui; C Caillard; P Rodien; M Roy; J L Peix; F Pattou; L Brunaud; J F Henry; E Mirallié
Journal:  Langenbecks Arch Surg       Date:  2012-12-19       Impact factor: 3.445

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.